Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus

Growth Hormone and IGF Research

Volumn 17, Issue 3, 2007, Pages 186-193

  Akturk, Mujde ^a   Arslan, Metin ^a   Altinova, Alev ^a   Ozdemir, Aysegul ^a   Ersoy, Reyhan ^b   Yetkin, Ilhan ^a   Ayvali, Elif ^a   Gonen, Sevim ^a   Toruner, Fusun ^a  

^a GAZI UNIVERSITY   (Turkey)

^b ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Creatinine clearance; Insulin like growth factor binding protein 1; Insulin like growth factor I; Type 2 diabetes; Urinary N acetyl d glucosaminidase

Indexed keywords

ALBUMIN; CREATININE; INSULIN; N ACETYL BETA GLUCOSAMINIDASE; ORAL ANTIDIABETIC AGENT; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DISEASE COURSE; FEMALE; HUMAN; IMMUNORADIOMETRIC ASSAY; INSULIN TREATMENT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIPLE REGRESSION; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; URINARY EXCRETION;

ACETYLGLUCOSAMINIDASE; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; MIDDLE AGED;

EID: 34249992917     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2007.01.007     Document Type: Article

References (30)

1. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm. IGF Res. 14 (2004) 337-375
2. Dunger D.B., Ong K.K., and Sandhu M.S. Serum insulin-like growth factor-I levels and potential risk of type 2 diabetes. Horm. Res. 60 Suppl. 3 (2003) 131-135
3. Janssen J.A., and Lamberts S.W. Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clin. Endocrinol. 52 (2000) 1-9
4. Thrailkill K.M. Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility. Diabetes Technol. Ther. 2 (2000) 69-80
5. Janssen J.A., and Lamberts S.W. The role of IGF-I in the development of cardiovascular disease in type 2 diabetes mellitus: Is prevention possible?. Eur. J. Endocrinol. 146 (2002) 467-477
6. Tan K., and Baxter R.C. Serum insulin-like growth factor I levels in adult diabetic patients: the effect of age. J. Clin. Endocrinol. Metab. 63 (1986) 651-655
7. Heald A.H., Cruickshank J.K., Riste L.K., Cade J.E., Anderson S., Greenhalgh A., et al. Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations. Diabetologia 44 (2001) 333-339
8. Jehle P.M., Jehle D.R., Mohan S., and Bohm B.O. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients. J. Endocrinol. 159 (1998) 297-306
9. Clauson P.G., Brismar K., Hall K., Linnarsson R., and Grill V. Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. Scand. J. Clin. Lab Invest. 58 (1998) 353-360
10. Schrijvers B.F., De Vriese A.S., and Flyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr. Rev. 25 (2004) 971-1010
11. Janssen J.A., Jacobs M.L., Derkx F.H., Weber R.F., van der Lely A.J., and Lamberts S.W. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 82 (1997) 2809-2815
12. Verrotti A., Cieri F., Petitti M.T., Morgese G., and Chiarelli F. Growth hormone and IGF-I in diabetic children with and without microalbuminuria. Diabetes Nutr. Metab. 12 (1999) 271-276
13. Sen A., and Buyukgebiz A. Albumin excretion rate, serum insulin-like growth factor-I and glomerular filtration rate in type I diabetes mellitus at puberty. J. Pediatr. Endocrinol. Metab. 10 (1997) 209-215
14. Bacci S., De Cosmo S., Garruba M., Placentino G., Liuzzi A., Barbano F., et al. Role of insulin-like growth factor (IGF)-1 in the modulation of renal haemodynamics in Type I diabetic patients. Diabetologia 43 (2000) 922-926
15. Amin R., Schultz C., Ong K., Frystyk J., Dalton R.N., Perry L., et al. Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study. Diabetes Care 26 (2003) 1456-1461
16. Wedrychowicz A., Dziatkowiak H., Nazim J., and Sztefko K. Insulin-like growth factor-1 and its binding proteins IGFBP-1, and IGFBP-3, in adolescents with type-1 diabetes mellitus and microalbuminuria. Horm. Res. 63 (2005) 245-251
17. Montauban van Swijndregt A.D., De Lange E.E., De Groot E., and Ackerstaff R.G.A. An in vivo evaluation of the reproducibility of intima-media thickness measurements of the carotid artery segments using B-mode ultrasound. Ultrasound Med. Biol. 25 (1999) 323-330
18. Cortizo A.M., Lee P.D., Cedola N.V., Jasper H., and Gagliardino J.J. Relationship between non-enzymatic glycosylation and changes in serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in patients with type 2 diabetes mellitus. Acta Diabetol. 35 (1998) 85-90
19. Shishko P.I., Dreval A.V., Abugova I.A., Zajarny I.U., and Goncharov V.C. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion. Diabetes Res. Clin. Pract. 25 (1994) 1-12
20. Mohamed-Ali V., Pinkney J.H., Panahloo A., Cwyfan-Hughes S., Holly J.M., and Yudkin J.S. Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome. Clin. Endocrinol. 50 (1999) 221-228
21. Gibson J.M., Westwood M., Young R.J., and White A. Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in non-insulin dependent diabetes mellitus (NIDDM). J. Clin. Endocrinol. Metab. 81 (1996) 860-863
22. Rutanen E.M., Karkkainen T., Stenman U.H., and Yki-Jarvinen H. Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J. Clin. Endocrinol. Metab. 77 (1993) 1152-1155
23. Frystyk J., Ivarsen P., Skjaerbaek C., Flyvbjerg A., Pedersen E.B., and Orskov H. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure. Kidney Int. 56 (1999) 2076-2084
24. Jehle P.M., Ostertag A., Schulten K., Schulz W., Jehle D.R., Stracke S., Fiedler R., Deuber H.J., Keller F., Boehm B.O., Baylink D.J., and Mohan S. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy. Kidney Int. 57 (2000) 423-436
25. Tonshoff B., Blum W.F., Wingen A.M., and Mehls O. Serum insulin-like growth factors (IGFs) IGF binding proteins 1, 2, 3 in children with chronic renal failure: relationship to height and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J. Clin. Endocrinol. Metab. 80 (1995) 2684-2691
26. Tonshoff B., Kiepe D., and Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr. Nephrol. 20 (2005) 279-289
27. Frystyk J., Bek T., Flyvbjerg A., Skjaerbaek C., and Orskov H. The relationship between the circulating IGF system and the presence of retinopathy in Type 1 diabetic patients. Diabet. Med. 20 (2003) 269-276
28. Bosomworth M.P., Aparicio S.R., and Hay A.W. Urine N-acetyl-β-d-glucosaminidase - a marker of tubular damage?. Nephrol. Dial. Transplant 14 (1999) 620-626
29. Kunin C.M., Chesney R.W., Craig W.A., England A.C., and DeAngelis C. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Pediatrics 62 (1978) 751-760
30. Le Hir M., Dubach U.C., and Schmidt U. Quantitative distribution of lysosomal hydrolases in the rat nephron. Histochemistry 63 (1979) 245-251